Bausch Health Companies | VRX - Assets



Bausch Health Companies reported $27.27B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Amgen USD 87.9B 1.47B Jun/2025
ANI Pharmaceuticals USD 1.34B 50.57M Jun/2025
Aurora Cannabis CAD 837.84M 28.68M Jun/2025
Bausch Health Companies USD 27.27B 845M Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Canopy Growth CAD 904.67M 259.55M Jun/2025
Corcept Therapeutics USD 801.72M 44.73M Jun/2025
Danaher USD 81.62B 2.5B Jun/2025
Drreddys Laboratories INR 519.54B 38.48B Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Gilead Sciences USD 55.72B 713M Jun/2025
Novo Nordisk 482.15B 7.01B Jun/2025
Pacira USD 1.54B 49.41M Jun/2025
Perrigo USD 10.09B 334.3M Jun/2025
Prestige Brands USD 3.43B 29.41M Jun/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025
Vertex Pharmaceuticals USD 24.04B 1.16B Jun/2025
Zoetis USD 14.48B 381M Jun/2025